EVGN Evogene Ltd.

Evogene Ltd is a biotechnology company for the improvement of crop productivity. It utilizes a proprietary integrated technology infrastructure to enhance seed traits underlying crop productivity.

$0.76  -0.02 (-2.58%)
As of 09/26/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Israel
Country of incorporation:  
IPO date:  02/19/2013
Outstanding shares:  41,202,018
Average volume:  89,189
Market cap:   $32,141,694
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Valuation   (See tab for details)
PE ratio:   -1.16
PB ratio:   0.60
PS ratio:   34.56
Return on equity:   -51.44%
Net income %:   -2,988.49%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy